MindBio Therapeutics (XCNQ:MBIO) Price-to-Operating-Cash-Flow : (As of May. 28, 2024)

View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Price-to-Operating-Cash-Flow?

As of today (2024-05-28), MindBio Therapeutics's share price is C$0.045. MindBio Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.01. Hence, MindBio Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for MindBio Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

XCNQ:MBIO's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.25
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

MindBio Therapeutics's Cash Flow from Operations per share for the three months ended in Mar. 2024 was C$0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.01.

MindBio Therapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for MindBio Therapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics Price-to-Operating-Cash-Flow Chart

MindBio Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

Price-to-Operating-Cash-Flow

MindBio Therapeutics Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of MindBio Therapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, MindBio Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MindBio Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MindBio Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where MindBio Therapeutics's Price-to-Operating-Cash-Flow falls into.

MindBio Therapeutics Price-to-Operating-Cash-Flow Calculation

MindBio Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.045	/	-0.007
	=

MindBio Therapeutics's Share Price of today is C$0.045.
MindBio Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.01.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

MindBio Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

MindBio Therapeutics (XCNQ:MBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

WF6:Germany

Address

91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000

Website

https://www.mindbiotherapeutics.com

MindBio Therapeutics Corp is pioneering clinical studies into the microdosing of psychedelic medicines to treat a range of medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. Its clinical trials microdosing of psychedelic medicines provide hope for sufferers of mental health conditions with new emerging treatment alternatives. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough microdosing studies. Geographically, the activities of the company takes place in Australia.